• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Risk factors associated with cognitive impairment development in older adults

byDonika YakoubandAlex Chan
January 18, 2024
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
Risk factors associated with cognitive impairment development in older adults
Share on FacebookShare on TwitterShare on LinkedIn

1. This longitudinal prospective cohort study found that older adults with trajectories involving impairments to instrumental activities of daily living, higher comorbidity, and increasing depressive symptoms were particularly at risk for developing cognitive impairment.

Evidence Rating Level: 2 (Good)

The global population is rapidly aging, and with this comes an increased incidence of morbidity and disease burden. In particular, cognitive impairment – marked by difficulties with memory, learning, concentration, and decision-making – will continue to burden the aging population. Thus, a preventative approach aimed towards identifying risk factors for dementia and cognitive impairment are of great importance. Previous literature has pointed to factors including sleep disorders, depression, functional limitations, and multimorbidity as correlates for cognitive impairment, but their trajectories through the lifespan are often neglected in the reporting of results. The current study made use of 8 years worth of measurement data from the Health and Retirement Study (HRS) to identify correlations between long-term health status and cognitive impairment. After implementing exclusion criteria, over 4319 adults older than 60 (mean [SD] age, 75.5 (5.55); 61.4% female) had demographic and health data analyzed, including several measures for sleep disturbance, functional status, and depressive symptoms over the course of 8 years. Those who reported sleep disturbances, increasing limitations on activities of daily living (ADLs/IADLs), and increasing scores on depression inventories over the years were more likely to be older, female, less educated, overweight, and sedentary. On an assessment of those participants that developed cognitive impairment, high multimorbidity status (HR = 1.89; 95% CI = 1.49–2.39), worsening depressive symptoms (HR = 1.80; 95% CI = 1.53–2.12), limitations in ADLs (HR = 1.88; 95% CI = 1.54–2.31), and IADLs (HR = 2.98; 95% CI = 2.34–3.78) presented heightened risk for cognitive impairment. Interestingly, the effects of increasing difficulty with IADLs (e.g., using the telephone, managing money, taking medications, shopping for groceries, and preparing hot meals) were more strongly correlated with cognitive impairment for older adults living in urban areas (HR = 2.30; 95% CI = 1.65–3.21; P for interaction = 0.049) compared to rural areas. The interaction of IADL impairment and cognitive impairment was also stronger in those with a history of smoking (HR = 2.77; 95% CI = 1.91–4.02; P for interaction = 0.033). For every point increase in the total score of risk trajectories, risk for cognitive impairment increased by 49%. Overall, the results of this study indicate that there exists a co-occurrence between physical, psychological, and neurocognitive disorders. A randomized trial should be implemented in the future to explore the effects of early intervention for these conditions, particularly for patients in the identified at-risk groups. 

Click to read the study in BMC Medicine

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

RELATED REPORTS

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

2 Minute Medicine Rewind October 12, 2026

Tags: chronic diseasecognitive impairmentdementianeurologyneuropsychiatry
Previous Post

#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with HER2-positive gastro-esophageal cancer

Next Post

At-Home Eccentric Exercises Improve Functional Ability More Than Stretching in Older Women

RelatedReports

A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 17, 2026
An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Dementia diagnosis underreporting is common and associated with reduced care engagement

August 29, 2026
Next Post
Exercise intervention linked to reduced functional decline among elderly patients admitted to the hospital

At-Home Eccentric Exercises Improve Functional Ability More Than Stretching in Older Women

#VisualAbstract: Curcumin-piperine supplementation may lead to lower inflammation in post-stroke patients

#VisualAbstract: Curcumin-piperine supplementation may lead to lower inflammation in post-stroke patients

#VisualAbstract: Perioperative Toripalimab Plus Chemotherapy Improves Event-Free Survival in Patients With Resectable Non–Small-Cell Lung Cancer

#VisualAbstract: Perioperative Toripalimab Plus Chemotherapy Improves Event-Free Survival in Patients With Resectable Non–Small-Cell Lung Cancer

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.